1. Which of the following is the most powerful predictor of first-episode relapse?

2. A patient stabilized on 3 mg of oral risperidone should be converted to which dose of SQ risperidone?

3. How long after administering the aripiprazole lauroxil nanocrystal technology does a provider have to administer the aripiprazole lauroxil injection?

4. How many cycles are required when mixing subcutaneous risperidone?

« Return to Activity